Effects of laughter yoga and mindfulness on women with breast cancer
The Effects of Laughter Yoga and Mindfulness-based Stress Reduction (MBSR) Practices Applied to Women With Breast Cancer Receiving Chemotherapy on Anxiety, Depression, Quality of Life and Spiritual Well-being Levels: A Randomized Controlled Study
This study tests if laughter yoga and mindfulness can help women with breast cancer feel better during chemotherapy by reducing anxiety and improving their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 105 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | Female |
| Sponsor | Kafkas University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (İskenderun, Hatay) |
| Trial ID | NCT06116812 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of laughter yoga and mindfulness-based stress reduction (MBSR) practices on women undergoing chemotherapy for breast cancer. Participants will be divided into two groups, one practicing laughter yoga and the other engaging in mindfulness techniques, to assess improvements in quality of life, anxiety, and depression. The study aims to provide supportive interventions that may alleviate some of the psychological and emotional burdens associated with breast cancer treatment. Women eligible for the study must be receiving chemotherapy and have elevated anxiety or depression scores.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 and older with stage 1 or stage 2 breast cancer who are currently receiving chemotherapy and have elevated anxiety or depression scores.
Not a fit: Patients who are not undergoing chemotherapy or those who do not meet the inclusion criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the emotional well-being and quality of life for women undergoing treatment for breast cancer.
How similar studies have performed: Other studies have shown positive outcomes with mindfulness and laughter therapies in cancer care, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women who are 18 years of age or older, do not have communication problems, have and can use a smartphone, do not have internet problems to participate in group sessions, volunteer to participate in the study, receive chemotherapy at least once a month and will continue to receive chemotherapy during the study. Women with stage 1 and stage 2 breast cancer, women with primary and secondary education, women within the first year of treatment in terms of the number of cycles, women with a score of 8 or more on the Hospital anxiety and depression scale (0-7 points are normal, 8- A score of 10 is borderline, 11 and above indicates abnormality). Exclusion Criteria: * Women who did not meet the inclusion criteria, refused to participate in the study, and participated in less than 80% of the research practices (It is recommended to participate in at least 6 out of 8 sessions in the literature (Liu et al. 2022).), * Women who use mindfulness therapy, laughter therapy or any complementary or integrative medicine in their daily lives outside the research, women who have a diagnosed psychological disease, metastasis or recurrence, and whose chemotherapy treatment was terminated before the study was completed, * Women with stage 3 and stage 4 breast cancer, women who have been receiving chemotherapy for more than 1 year, women whose scores are 8 or below on the Hospital anxiety and depression scale (0-7 points indicate normal, 8-10 points indicate borderline, 11 and above indicate abnormality ).
Where this trial is running
İskenderun, Hatay
- Hatay Iskenderun State Hospital — İskenderun, Hatay, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: zehra Coktay, phd stu — Kafkas University
- Study coordinator: Zehra Coktay, phd stu
- Email: zehracoktay1@gmail.com
- Phone: +90 5432035243
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.